Overview

Sb-705498 Rectal Pain Study

Status:
Terminated
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
SB-705498 has demonstrated efficacy in several preclinical and human experimental pain models. This study will investigate the efficacy of SB-705498 in patients with rectal pain. This will be a double-blind, placebo-controlled, two-way crossover study. 21 patients with faecal urgency (Group 1), and 21 patients with IBS (Group 2) will complete this study.
Phase:
Phase 2
Details
Lead Sponsor:
GlaxoSmithKline